Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo.
Liu J, Zhang R, Su T, Zhou Q, Gao L, He Z, Wang X, Zhao J, Xing Y, Sun F, Cai W, Wang X, Han J, Qin R, Désaubry L, Han B, Chen W.
Liu J, et al. Among authors: wang x.
J Exp Clin Cancer Res. 2023 May 20;42(1):128. doi: 10.1186/s13046-023-02695-0.
J Exp Clin Cancer Res. 2023.
PMID: 37210546
Free PMC article.